BlinkLab Limited (BB1.AX)
ASX · AUD · Healthcare · Health Information Services
A$0.61 (-1.61%) as of
Key statistics
- Market cap
- 107.56M
- Forward P/E
- -12.45
- EPS (TTM)
- -0.0600
- Dividend yield
- 0.00%
- 52-week range
- 0.5600 – 1.1050
- Beta
- 1.45
- Revenue (TTM)
- 1.21M
- Profit margin
- 0.00%
- Analyst target
- A$2.24
- Volume
- 57.85k
About BlinkLab Limited
BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-based neurobehavioural testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations and objective sensorimotor biomarkers, which provides scientific support for future regulatory approval and clinical adoption. The company's application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Perth, Australia.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Perth, WA, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.